Goldman Sachs analysts added Houlihan Lokey (HLI) to the firm’s US Conviction List as part of its monthly update. Houlihan offers “best-in-class protection” from an economic slowdown through its restructuring business and skew to the “healthier” mid-cap and sponsor businesses, Goldman contends. The firm has a Buy rating on the shares with a $182 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLI:
- Houlihan Lokey price target lowered to $170 from $179 at Wells Fargo
- Houlihan Lokey price target lowered to $156 from $190 at Morgan Stanley
- Houlihan Lokey upgraded to Overweight from Underweight at Morgan Stanley
- Wells double upgrades Houlihan to Overweight Lokey on ‘defensibility’
- Houlihan Lokey upgraded to Overweight from Underweight at Wells Fargo